Robert Carter

Robert Carter

atStarling Oncology· In proxies 2024–2025

Pay in FY2025+69% from the year before · Starling Oncology stock +1,052.1% the same year

Robert Carter was paid $734.1K in FY2025 (Dec), up 69%. Starling Oncology stock rose 1,052.1% that year.

Pay$100 in the stock at the end of FY23 → $175
Pay is from the Summary Compensation Table of each Starling Oncology proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Starling OncologyPublic company · 2 yr
    • 2024 – Present · 2 yrStock in role +227%

Roles come from the proxy statements of each company.

Activity

Two people shown as one, or a wrong number?